| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5691046 | Contraception | 2016 | 32 Pages |
Abstract
Limited evidence suggests a two- to fourfold increased risk of stroke among women with migraine who use COCs compared with nonuse. Additional study is needed on the risks of hormonal contraceptives, including combined and progestin-only methods, among women with different migraine subtypes.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Naomi K. Tepper, Maura K. Whiteman, Lauren B. Zapata, Polly A. Marchbanks, Kathryn M. Curtis,